Maia Beridze MD. Ph.D.

Education:

• 1979- 1984  – Tbilisi State Medical Institute (current name is Tbilisi State Medical University), Diploma KV #146107;
• Postgraduate clinical studies in Neurology (equivalent of Residency), State Institute of   Postgraduate Medical Studies, Certificate N 387-13/1-1987;
• High qualification courses in Neurology, Diploma N1143-15/V-1991;
• Tbilisi State Institute of Foreign Languages, English Department, High Courses of Simultaneous translation, Certificate #-805;
• High Computer Courses, Certificate #AA1-000-03.

Professional Qualification:

• Clinical Qualification, Neurological Clinic of Krams University sponsored by EFNS (Donau-Universitat  krams, Department of Neurology, Landesnervenklinik, Haupstrasse 2, A-340, Maria Gugging, Austria)
• Clinical Qualification, Neurological Clinic of Ankara Numune Training and Research Hospital sponsored by Health Ministry of Turkey (Ankara Turkey )
• Clinical Qualification, Neurological department of  Ikhilov  Hospital, Souraski Medical Center, Telaviv University, sponsored by MASHAV Program (Telaviv, Israel)
• Qualification in Cognitive Neuroscience, School of Neuropsychology, Edinburgh University, UK (7 George Square EH8  9JZ) (British Royal  Society Grant).

Dissertations:

• Academic qualification -Ph.D. (Candidate Medical Sciences)
  Several Immunological Indexes in acute phase of stroke and their changeng by application of immunomodulator Plaferon-LB.  Beritashvili Institute of Physiology, Board of Academic Experts of Georgia B.03.13c, N2, Protocol  N 4-38; 15.06.1999;
  Diploma of Candidate Medical Sciences (equivalent of Ph.D.) N 002332, Tbilisi, 1999;

• Academic qualification- ScD (Doctor of Medical Sciences)
  The role of several pro-apoptotic factors and several indexes of endogenous protection system in the evolution of acute cerebral ischemia, Beritashvili Institute of Physiology, Board of Academic Experts of Georgia B.03.13c, Protocol #5, 13.10. 2009;
  Diploma of Doctor Medical Sciences (ScD) # 001731, Tbilisi 2006.

• 1985-1987 – Residency in Neurology, 9th Clinical Hospital, Tbilisi, Georgia;
• 1987-1999 – Doctor Neurologist, Department of Neurology of N2 Hospital, Tbilisi, Georgia;
• 1999-2006 – Assistant professor of Neurology, Department of Neurology, Georgian State Medical Academy; 9^th Clinical Hospital;
• 2006- 2009 – Assistant professor of Neurology, Department of Neuromedicine, Tbilisi State Medical University, Khechinashvili University Hospital;
• 2009- 2014 – Associated professor of Neurology, Department of Neuromedicine, Tbilisi State Medical University;
• 2009-2011 – LTD Railway Clinical Hospital, Chief of the Clinical Neurological Service;
• 2011-2015 – University Clinical Center LTD “DEKA”, Professor of Neurological Department;
• Since 2014-till now – Program Director of Residency in Neurology, Tbilisi State Medical University;
• Since 2015-till now – Full Professor of Neurology, Tbilisi State Medical University;
• Since 2015-till now – The Head of Neurological Department, The First University Clinic of Tbilisi State Medical University.

National and International Scientific Projects:

1. 2001-2004  INTAS Project grant “Ras participation in Neurological diseases”, Chief of the CR3 research unit.
2. 2003-2004 World Health Organization Project “WHO Survey”, Administration Secretary, Researcher.
3. 2003-2004  Ministry of Health, Labor and Social Affairs project Grant  “Identification of stroke risk-factors in Georgian population”, Researcher.
4. 2005-2006 British Royal Society Grant Project “Dual-Task impairment in different types of dementia”, Researcher.

Publications:

• 92 scientific publications in national and international scientific journals

 Monograph

• R.Shakarishvili, M. Beridze, – Acute Cerebral Ischemia, Assays of Clinical Neurochemistry-Editorial – Biomed, 2009, Tbilisi, Georgia;

Study books:

“Clinical Neurology” by M. Janelidze, Chapter 16 M. Beridze– Cerebrovascular Diseases-65 pages. –In Georgian Language;

“Therapeutic Riding, Hypotherapy” by D. Tsverava, Chapter 8,p. 37-55, M. Beridze-Psychophysiolgical basics of treatment of  Child Cerebral Palsy by hypotherapy,  Editorial of Ilia State University, 2012.

Clinical Trials:

• 2008-2009 – Multicenter prevalence study “SIFAP- Stroke in Young Fabry Patients”- Rostock University, Germany;
• 2008-2010 – Multicenter  double blinded study “ORACLE-MS”, Merck Sereno
• 2011 – Multicenter Trial “ENOS-Efficiency of Nitric Oxide in Stroke”  -Nottingham University, UK
• 2011 – Multicenter double blinded International Trial in MS, Biogen Idec. 105MS301 ADVANCE;  2012-105MS302
• 2012 – Multicenter double blinded International Trial  in MS, Synthon, GTR 001, GATE;
• 2012 – Multicenter double blinded International Trial in MS, TEVA 2012, GA-MS 302;
• 2013 – Multicenter double blinded International Trial  in  MS, TEVA LAQ-MS-305 (CONCERTO)
• 2014-16 – Multicenter International Trial “TARDIS- Tripple Antiplatelets for Reducung Dependency after Ischemic Stroke”- The University of Nottingham, UK
• From 2014 – Multicenter International Trial “TICH-Tranexamic Acid in patients with Hemmorhagic stroke”, The University of Nottingham, UK
• From 2015 – Multicenter, Phase III, double-blinded International Trial in MS, PRPC01-301 (RECEPTO);
• From 2016 – Multicenter, Phase III, International Clinical Trial in Ischemic Stroke, Impact-24, Brainsgate.

• Member of Georgian Association of Neurologists and Neurosurgeons,
• Member of European Academy of Neurology(EAE),
• Member of World Federation of Neurology,
• Member of World Stroke Federation,
• Member of IBRO (International Brain Research Organization),
• Member of Executive Committee of Georgian Association of Therapeutic Riding,
• Member of Executive Committee of Georgian Association of Neurosciences,
• Expert of Georgian National Science Fund.

• 51 National and International Congresses, oral and poster presentations.

Georgian – Native
Russian – Good
English – Good